Display options
Cite
Filippatos G, Farmakis D, Metra M, et al. Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol. 2017;106(11):938doi: 10.1007/s00392-017-1139-5.
Filippatos, G., Farmakis, D., Metra, M., Cotter, G., Davison, B. A., Felker, G. M., Greenberg, B. H., Hua, T. A., Pang, P. S., Ponikowski, P., Qian, M., Severin, T. A., Voors, A. A., & Teerlink, J. R. (2017). Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clinical research in cardiology : official journal of the German Cardiac Society, 106(11), 938. https://doi.org/10.1007/s00392-017-1139-5
Filippatos, Gerasimos, et al. "Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial." Clinical research in cardiology : official journal of the German Cardiac Society vol. 106,11 (2017): 938. doi: https://doi.org/10.1007/s00392-017-1139-5
Filippatos G, Farmakis D, Metra M, Cotter G, Davison BA, Felker GM, Greenberg BH, Hua TA, Pang PS, Ponikowski P, Qian M, Severin TA, Voors AA, Teerlink JR. Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol. 2017 Nov;106(11):938. doi: 10.1007/s00392-017-1139-5. PMID: 28752374; PMCID: PMC6828441.
Copy Download .nbib Format: NLM
Share it on

Clin Res Cardiol. 2017 Nov;106(11):938. doi: 10.1007/s00392-017-1139-5.

Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Clinical research in cardiology : official journal of the German Cardiac Society

Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, Gad Cotter, Beth A Davison, G Michael Felker, Barry H Greenberg, Tsushung A Hua, Peter S Pang, Piotr Ponikowski, Min Qian, Thomas A Severin, Adriaan A Voors, John R Teerlink

Affiliations

  1. National and Kapodistrian University of Athens, Medical School, Athens, Greece. [email protected].
  2. Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, 1 Rimini St, 12462, Athens, Greece. [email protected].
  3. National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  4. University of Brescia, Brescia, Italy.
  5. Momentum Research Inc., Durham, NC, USA.
  6. Duke Clinical Research Institute, Durham, NC, USA.
  7. University of California at San Diego, San Diego, CA, USA.
  8. Novartis Pharmaceuticals Corporation, New Hanover, NJ, USA.
  9. Indiana University School of Medicine and Regenstrief Institute, Indianapolis, IN, USA.
  10. Clinical Military Hospital, Medical University, Wroclaw, Poland.
  11. Columbia University, New York, NY, USA.
  12. Novartis Pharma AG, Basel, Switzerland.
  13. University of Groningen, Groningen, The Netherlands.
  14. University of California-San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.

PMID: 28752374 PMCID: PMC6828441 DOI: 10.1007/s00392-017-1139-5

[No abstract available.]

Publication Types